Nektar Therapeutics/$NKTR
About Nektar Therapeutics
Ticker
Industry
Employees
NKTR Metrics
$166M
-
-$0.84
0.61
-
Price and volume
Market cap
$166M
Beta
0.61
52-week high
$1.93
52-week low
$0.48
Average daily volume
1.9M
Financial strength
Current ratio
4.239
Quick ratio
3.649
Long term debt to equity
377.602
Total debt to equity
421.592
Interest coverage (TTM)
-5.47%
Management effectiveness
Return on assets (TTM)
-22.64%
Return on equity (TTM)
-161.63%
Valuation
Price to revenue (TTM)
1.942
Price to book
3.85
Price to tangible book (TTM)
3.85
Price to free cash flow (TTM)
-1.017
Growth
Revenue change (TTM)
5.53%
Earnings per share change (TTM)
-46.11%
3-year revenue growth (CAGR)
-2.46%
3-year earnings per share growth (CAGR)
-32.50%
What the Analysts think about NKTR
Analyst Ratings
NKTR Financial Performance
Income Statement
Q3 24
QoQ growth
$37B
-39.75%
$45B
107.52%
37.65%
6.78%
NKTR Earnings Performance
Earnings per share (EPS)
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
$3.69
$2.85
$2.45
$2.42
-
$3.55
$2.61
$2.05
$2.31
$3.94
3.94%
9.20%
19.51%
4.63%
-
NKTR News
FAQs
What’s the current market cap for Nektar Therapeutics stock?
What is the P/E ratio for Nektar Therapeutics stock?
Does Nektar Therapeutics stock pay dividends?
No, Nektar Therapeutics (NKTR) stock does not pay dividends to its shareholders as of January 15, 2025.
When is the next Nektar Therapeutics dividend payment date?
Nektar Therapeutics (NKTR) stock does not pay dividends to its shareholders.
What is the beta indicator for Nektar Therapeutics?
Nektar Therapeutics (NKTR) has a beta rating of 0.61. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.